-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K1SmLulj2mp4r1yJNXA5TVOsHB47WoVVtG13LXU8c9RufgM0VT9jzp05y1witQmG XN4V4vH8M3AzEuQyIAEbYw== 0001104659-05-013143.txt : 20050328 0001104659-05-013143.hdr.sgml : 20050328 20050328174326 ACCESSION NUMBER: 0001104659-05-013143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050324 FILED AS OF DATE: 20050328 DATE AS OF CHANGE: 20050328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173490200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirby Neil CENTRAL INDEX KEY: 0001308655 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21481 FILM NUMBER: 05707528 BUSINESS ADDRESS: BUSINESS PHONE: 617-349-0200 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0202 4 2005-03-24 0 0000885259 TRANSKARYOTIC THERAPIES INC TKTX 0001308655 Kirby Neil 700 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Sr. VP, Strategic Prod. Dev. Stock Option (right to buy) 23.79 2005-03-24 4 A 0 15000 0 A 2015-03-24 Common Stock 15000 15000 D The option becomes exercisable in three equal annual installments beginning on March 24, 2006. /s/ Neil Kirby 2005-03-28 -----END PRIVACY-ENHANCED MESSAGE-----